Allarity Therapeutics, Inc. (ALLR)
NASDAQ: ALLR · Real-Time Price · USD
1.300
+0.030 (2.36%)
At close: Jun 26, 2026, 4:00 PM EDT
1.327
+0.027 (2.07%)
After-hours: Jun 26, 2026, 7:58 PM EDT
Allarity Therapeutics Market Cap
Allarity Therapeutics has a market cap or net worth of $20.68 million as of June 26, 2026. Its market cap has increased by 55.32% in one year.
Market Cap
20.68M
Enterprise Value
22.37M
1-Year Change
55.32%
Ranking
Category
Stock Price
$1.30
Market Cap Chart
Since December 21, 2021, Allarity Therapeutics's market cap has decreased from $79.38M to $20.68M, a decrease of -73.94%. That is a compound annual growth rate of -25.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 20.68M | 21.20% |
| Dec 31, 2025 | 17.07M | 229.00% |
| Dec 31, 2024 | 5.19M | 106.50% |
| Dec 29, 2023 | 2.51M | -40.12% |
| Dec 30, 2022 | 4.20M | -94.65% |
| Dec 31, 2021 | 78.43M | -1.20% |
| Dec 21, 2021 | 79.38M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Longeveron | 22.29M |
| Marker Therapeutics | 21.93M |
| Pluri | 21.92M |
| VYNE Therapeutics | 21.62M |
| Polyrizon | 21.53M |
| NewcelX | 20.46M |
| Lipocine | 20.28M |
| Cellectar Biosciences | 20.14M |